Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology

Understanding Woodhouse-Sakati Syndrome

At a Glance

Woodhouse-Sakati syndrome is an ultra-rare inherited disorder caused by changes in both copies of DCAF17. It mainly affects hormone production and the brain and nerves, and its symptoms can be managed through individualized treatment and coordinated specialist care.

Receiving a diagnosis of Woodhouse-Sakati syndrome (WSS) can feel overwhelming, especially when you discover how few people in the world share this journey. It is what doctors call an ultra-rare condition, meaning it is seen so infrequently that many healthcare providers may never have heard of it [1].

You may find yourself in the position of educating your own local doctors about your or your child’s needs. This page is designed to help you understand the basics of WSS so you can advocate for the specialized care you deserve.

What is Woodhouse-Sakati Syndrome?

Woodhouse-Sakati syndrome is a rare genetic disorder that affects multiple systems in the body, primarily the endocrine system (hormones) and the nervous system (brain and nerves) [1]. It is caused by pathogenic variants in a gene called DCAF17 [2].

In a healthy body, genes act like instruction manuals for building proteins. When both copies of the DCAF17 gene have a pathogenic variant, the body cannot produce the protein correctly, which leads to the various symptoms of WSS [1][3]. Because it is an autosomal recessive condition, it only occurs when a person inherits one mutated copy of the gene from each parent [3].

How Rare is WSS?

WSS is exceptionally rare. A comprehensive 2022 review of medical literature found approximately 185 reported cases worldwide across 12 different countries [3]. While this number only accounts for patients who have been “published” in medical journals and true numbers may be higher, it highlights that you are part of a very small global community [1].

Because it is so rare, there is no “standard” experience. Even siblings with the same genetic mutation can have very different symptoms and outcomes [4][5].

A Multi-System Journey

WSS affects many parts of the body, but it does so at different times and in different ways for everyone. Research shows several common areas of concern:

  • Hormone (Endocrine) Health: Hypogonadism is very common, which is when the body does not produce enough sex hormones to start or complete puberty naturally [6][7]. Other common issues include diabetes mellitus and hypothyroidism (an underactive thyroid), which often develop later in life [6][8].
  • Physical Traits: Most individuals experience significant hair loss (alopecia) that often begins in childhood or adolescence [6][9].
  • Brain and Nerves (Neurologic): Some people develop movement issues, such as dystonia (involuntary muscle contractions) [4]. Others may experience hearing loss or differences in how they learn and process information [9][6].
  • Imaging Findings: Doctors often use MRI (magnetic resonance imaging) to look at the brain. In WSS, these scans may show a small pituitary gland (the master hormone gland) or small deposits of iron in certain parts of the brain, though these are not present in every person [10].

At-A-Glance: While alopecia and hypogonadism are common, the onset of diabetes, thyroid issues, hearing loss, and neurological progression are highly variable. Because it is so rare, tests are often symptom-triggered rather than routine.

Navigating the Diagnosis

It is natural to feel fear when a diagnosis has no “cure,” but it is important to remember that WSS has many treatable symptoms. While we cannot change the DCAF17 gene itself, symptom-directed medicine can be effective at managing the challenges it causes [2].

For example, sex-steroid replacement therapy (HRT) can be used to induce puberty and support bone health, while separate treatments like levothyroxine manage thyroid function [11][12]. Diabetes can be managed with standard treatments, and specialists can help manage movement or hearing issues as they arise [2][13].

Building Your Care Team

Because WSS affects so many different parts of the body, you cannot rely on just one doctor. Research emphasizes the need for multidisciplinary care—a team of specialists working together [2]. Your team will likely include:

  1. A Geneticist to confirm the diagnosis and provide family counseling [2].
  2. An Endocrinologist to manage hormones, puberty, and blood sugar [6].
  3. A Neurologist to monitor brain health and movement [4].
  4. An Audiologist to monitor for hearing loss [9].
  5. A Primary Care Provider to serve as a medical home and care coordinator.

The goal of this care is not just to treat symptoms, but to ensure you or your child can live the most full and active life possible. Your journey with WSS is unique, and your medical team should treat it that way [5].

Common questions in this guide

What is Woodhouse-Sakati syndrome?
Woodhouse-Sakati syndrome, or WSS, is an ultra-rare inherited condition that mainly affects the hormone system and the brain and nerves. It can also affect hair growth, hearing, learning, and blood sugar or thyroid function, and symptoms vary widely from person to person.
How is Woodhouse-Sakati syndrome inherited?
WSS follows an autosomal recessive pattern, meaning a person develops the condition when both copies of the DCAF17 gene have a pathogenic variant, with one copy inherited from each parent. Genetic counseling can help families understand testing and inheritance.
What are the most common signs of WSS?
Hair loss and low sex-hormone production are common, and low sex hormones can cause delayed or incomplete puberty. Some people later develop diabetes or an underactive thyroid, while movement problems, hearing loss, and learning or information-processing differences vary between individuals.
Can Woodhouse-Sakati syndrome be treated?
There is no cure that changes the DCAF17 gene itself, but many effects of WSS can be managed. Sex-steroid replacement therapy can support puberty and bone health, levothyroxine can treat low thyroid function, and standard diabetes treatments or specialist care can address other needs.
Which specialists should be involved in WSS care?
Care is usually coordinated by a multidisciplinary team that may include a geneticist, endocrinologist, neurologist, audiologist, and primary care provider. The team can confirm the diagnosis, manage hormones and blood sugar, monitor neurologic and hearing concerns, and coordinate appointments.
What tests and monitoring might someone with WSS need?
There is no single testing schedule for everyone because WSS is rare and symptoms do not occur in the same way for each person. Depending on individual needs, clinicians may use brain MRI, hormone testing, hearing examinations, and evaluation for diabetes, thyroid problems, movement changes, or learning needs.

Get notified when new evidence is published on Woodhouse-Sakati syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Woodhouse-sakati syndrome with no reportable MRI findings: a case report.

    Irvine RE, Ahmad A

    BMC neurology 2024; (24(1)):359 doi:10.1186/s12883-024-03865-z.

    PMID: 39342163
  2. 2

    Three Siblings With Woodhouse-Sakati Syndrome: A Case Report of A New Saudi Family.

    Alhuzaim ON, Ahmad MM, Sherbeeni SM, et al.

    Cureus 2022; (14(12)):e32225 doi:10.7759/cureus.32225.

    PMID: 36620807
  3. 3

    Genetic epidemiology of Woodhouse-Sakati Syndrome in the Greater Middle East region and beyond: a systematic review.

    Kohil A, Abdallah AM, Hussain K, Al-Shafai M

    Orphanet journal of rare diseases 2023; (18(1)):22 doi:10.1186/s13023-023-02614-8.

    PMID: 36721231
  4. 4

    Patterns of neurological manifestations in Woodhouse-Sakati Syndrome.

    Bohlega S, Abusrair AH, Al-Ajlan FS, et al.

    Parkinsonism & related disorders 2019; (69()):99-103 doi:10.1016/j.parkreldis.2019.10.007.

    PMID: 31726291
  5. 5

    Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome.

    Almeqdadi M, Kemppainen JL, Pichurin PN, Gavrilova RH

    The American journal of case reports 2018; (19()):347-353 doi:10.12659/ajcr.907395.

    PMID: 29574468
  6. 6

    Expanding on the phenotypic spectrum of Woodhouse-Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review.

    Ali R, Al-Dewik N, Mohammed S, et al.

    American journal of medical genetics. Part A 2022; (188(1)):116-129 doi:10.1002/ajmg.a.62501.

    PMID: 34590781
  7. 7

    A novel DCAF17 homozygous mutation in a girl with Woodhouse-Sakati syndrome and review of the current literature.

    Kurnaz E, Türkyılmaz A, Yaralı O, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(11)):1287-1293.

    PMID: 31472064
  8. 8

    A case of Woodhouse-Sakati syndrome with pituitary iron deposition, cardiac and intestinal anomalies, with a novel mutation in DCAF17.

    Sendur SN, Oguz S, Utine GE, et al.

    European journal of medical genetics 2019; (62(8)):103687 doi:10.1016/j.ejmg.2019.103687.

    PMID: 31152917
  9. 9

    Woodhouse-Sakati Syndrome: First report of a Portuguese case.

    Louro P, Durães J, Oliveira D, et al.

    American journal of medical genetics. Part A 2019; (179(11)):2237-2240 doi:10.1002/ajmg.a.61303.

    PMID: 31347785
  10. 10

    Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.

    Abusrair AH, Bohlega S, Al-Semari A, et al.

    AJNR. American journal of neuroradiology 2018; (39(12)):2256-2262 doi:10.3174/ajnr.A5879.

    PMID: 30409855
  11. 11

    The Successful Management of Primary Amenorrhea in Woodhouse-Sakati Syndrome: A Case Report and a Literature Review.

    Bakhsh H, Alqntash N, Almajed E

    Life (Basel, Switzerland) 2023; (13(10)) doi:10.3390/life13102022.

    PMID: 37895404
  12. 12

    DCAF17 Mutation in Woodhouse-Sakati Syndrome: A Case Report on a Novel Homozygous Variant.

    Khalili Dehkordi A, Vakili R

    Case reports in pediatrics 2025; (2025()):9913412 doi:10.1155/crpe/9913412.

    PMID: 41058970
  13. 13

    Long-Term Outcomes of Deep Brain Stimulation in Woodhouse-Sakati Syndrome.

    Alhodaif H, Alkhodair Y, Alotaibi F, et al.

    Movement disorders : official journal of the Movement Disorder Society 2026; (41(6)):1427-1433 doi:10.1002/mds.70266.

    PMID: 41902420

This overview of Woodhouse-Sakati syndrome is for education and does not replace medical advice. Work with a qualified care team to interpret symptoms, testing, and treatment decisions for you or your child.